Latest News

Novartis Earnings Get a Boost From Sales of Its Key Drugs

0

Novartis said earnings and sales rose in the first quarter of the year, boosted by its key drugs, including heart failure treatment Entresto.

Net income was $2.2 billion, up from $1.8 billion in the same quarter the previous year, on sales that grew to $12.53 billion from $12.41 billion. Analysts expected sales of $12.62 billion.

Operating…

SMCP Sees Strong Q1 Organic Sales Boost

Previous article

UBS tops earnings estimate while booking $100 million Russian hit

Next article

You may also like

Comments

Leave a reply

Your email address will not be published.

More in Latest News